Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-22

Clinical Trial Update: Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women [NA]

View source ↗

Summary

A Duke University-sponsored feasibility trial evaluating a stigma-reduction intervention for HIV-infected women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Human Immunodeficiency Virus (HIV), Self-efficacy | NA | Status: COMPLETED